Possible contribution of artificial neural networks and linear discriminant analysis in recognition of patients with suspected atrophic body gastritis

World Journal of Gastroenterology

Volumn 11, Issue 37, 2005, Pages 5867-5873

  Lahner, Edith ^a   Grossi, Enzo ^b   Intraligi, Marco ^c   Buscema, Massimo ^c   Corleto, Vito D ^a   Fave, Gianfranco Delle ^a   Annibale, Bruno ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Bracco Imaging SpA   (Italy)

^c Semeion centro ricerche di scienze della communicazione   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Artificial neural networks; Atrophic body gastritis; Computer based decision support; Gastroscopy

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; ARTIFICIAL NEURAL NETWORK; ATROPHIC GASTRITIS; CELIAC DISEASE; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; FEMALE; GASTROSCOPY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREDICTION; PROCESS OPTIMIZATION; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; STOMACH BIOPSY;

EID: 27944470525     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i37.5867     Document Type: Article

References (43)

1. Lee EL, Feldman M. Gastritis and other gastropathies. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease: pathophysiology, diagnosis, management. Eds. Feldman M, Friedman LS, Sleisenger MH. 7th edition, Saunders, Philadelphia; 2002: 810-827
2. Peterson WL, Graham DY. Helicobacter pylori. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease: pathophysiology, diagnosis, management. Eds. Feldman M, Friedman LS, Sleisenger MH. 7th edition, Saunders, Philadelphia; 2002: 732-746
3. Marignani M, Delle Fave G, Mecarocci S, Bordi C, Angeletti S, D'Ambra G, Aprile MR, Corleto VD, Monarca B, Annibale B. High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study. Am J Gastroenterol 1999; 94: 766-772
4. Annibale B, Marignani M, Azzoni C, D'Ambra G, Caruana P, D'Adda T, Delle Fave G, Bordi C. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 1997; 2: 57-64
5. Kekki M, Samlof IM, Varis K, Ihamaki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991; 26: 109-116
6. Babio BM, Bunn HF. Megaloblastic anemias. In: Fauci AS, Braunwald E, Isselbacher KJ. Eds. Harrison's principles of internal medicine (14th edition ). McGraw Hill 1998: 653-659
7. Whittingham S, Mackay IR. Pernicious anemia and gastric atrophy. In: Rose NR, Mackay IR, Eds. The Autoimmune Diseases. Orlando, FL: Academic 1985: 243-266
8. Schade SG, Cohen RJ, Conrad ME. The effect of hydrochloric acid on iron absorption. N Engl J Med 1968; 279: 672-674
9. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1991; 337: 1441-1448
10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The Updated Sydney System. Am J Surg Pathol 1996; 20: 1161-1181
11. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, Leandro G, Price AB, Sipponen P, Solcia E, Watanabe H, Genta RM. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 1249-1259
12. Westerveld BD, Pals G, Lamers CB, Defize J, Pronk JC, Frants RR, Ooms EC, Kreuning J, Kostense PJ, Eriksson AW. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 1987; 59: 952-958
13. Ley C, Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol Biomark Prev 2001; 10: 107-112
14. Väänänen H, Vauhkone M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandstrom R, Ristikankare M, Jussila A, Sipponen P. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15: 885-891
15. Kuipers EJ. In through the out door: serology for atrophic gastritis. Eur J Gastroenterol Hepatol 2003; 15: 877-879
16. Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules: Applications and methodological standards. N Engl J Med 195; 313: 793-799
17. Dayhoff JE, DeLeo JM. Artificial Neural Networks. Opening the black box. Cancer 2001; 91: 1615-1635
18. Cross SS, Harrison RF, Kennedy RI. Introduction to neural networks. Lancet 1995; 346: 1075-1079
19. Wyatt JC. Decision support systems. J R Soc Med 2000; 93: 629-633
20. Buscema M. Special issue on artificial neural networks and complex social systems, I. Theory. Substance Use Misuse 1998; 33: 1-220
21. Detrano R, Janosi A, Steinbrunn W, Pfisterer M, Schmid JJ, Sandhu S, Guppy KH, Lee S, Froelicher V. International application of a new probability algorithm for the diagnosis of coronary artery disease. Am Cardiol 1989; 64: 304-310
22. Han M, Snow PB, Brandt JM, Partin AW. Evaluation of artificial neural networks for the rediction of pathologic state in prostate carcinoma. Cancer 2001; 91: 1661-1666
23. West D, West V. Model selection for a medical diagnostic decision support system: a breast cancer detection case. Artific Intell Med 2000; 20: 183-204
24. Blekas K, Stafylopatis A, KontoravdisD, Likas A, Karakitsos P. Cytological diagnosis based on fuzzy neural networks. J Intellt Systems 1998; 8: 55-79
25. Das A, Ben-Menachem T, Cooper GS, Chak A, Sivak MV Jr, Gonet JA, Wong RC. Prediction of outcome in acute lower-gastrointestinal haemorrhage based on an artificial neural network: internal and external validation of a predictive model. Lancet 2003; 362: 1261-1266
26. Selaru FM, Xu Y, Yin J, Zou T, Liu TC, Mori Y, Abraham JM, Sato F, Wang S, Twigg C, Olaru A, Shustova V, Leytin A, Hytiroglou P, Shibata D, Harpaz N, Meltzer SJ. Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology 2002; 122: 606-613
27. Bordi C, Annibale B, Azzoni C, Marignani M, Ferraro G, Antonelli G, D'Adda T, D'Ambra G, Delle Fave G. Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. J Pathol 1997; 182: 339-346
28. Annibale B, Severi C, Chistolini A, Antonelli G, Lahner E, Marcheggiano A, Iannoni C, Monarca B, Delle Fave G. Efficacy of a gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients. Am J Gastroenterol 2001; 96: 132-137
29. Marsh MN. Gluten, major histocompatibility complex and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivitiy ('celiac sprue'). Gastroenterology 1992; 102: 330-354
30. Buscema M. Back propagation neural networks. Substance Use Misuse 1998; 33: 233-270
31. Buscema M. Sine Net: a new learning rule for adaptive systems, Technical paper 21. Rome: Semeion 2000
32. Buscema M. Self-Recurrent neural network. Substance Use Misuse 1998; 33: 495-501
33. Breda M, Buscema M. Reti neurali ricorrenti. In M. Buscema Semeion Group, Reti Neurali Artificiali e Sistemi Sociali Complessi, Vol. I: Teoria e Modelli, Milan: Franco Angeli 1999: 440-464
34. Buscema M, Grossi E, Intraligi M, Garbagna N, Andriulli A, Breda M. An optimized experimental protocol based on neuroevolutionary algorithms. Application to the classification of dyspeptic patients and to the prediction of the effectiveness of their treatment. Artif Intell Med 2005; 34: 279-305
35. Buscema M. Genetic doping algorithm (GenD): theory and application. Exp Systems 2004; 2: 63-79
36. Buscema M. SuperVised Feed Forward and Recurrent ANNs, Research Software package for Supervised ANNs. Semeion Software 12, ver 3.0. Roma 2000
37. Annibale B, Capurso G, Chistolini A, D'Ambra G, DiGiulio E, Monarca B, DelleFave G. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms. Am J Med 2001; 111: 439-445
38. Tu VJ. Advantages and disadvantages of using artificial neural networks versus logistic regression for prediction medical outcomes. J Clin Epidemiol 1996; 49: 1225-1231
39. Levine RF. Clinical problems, computational solutions. A vision for a collaborative future. Cancer 2001; 91: 1595-1602
40. Buchman TG, Kubos KL, Seidler AJ, Siegforth MJ. A comparison of statistical and connectionist models for the prediction of chronicity in a surgical intensive care unit. Crit Care Med 1994; 22: 750-762
41. Sargent JD. Comparison of artificial neural networks with other statistical approaches. Cancer 2001; 91: 1636-1642
42. Cross SS, Harrison RF, Sanders DS. Supporting decisions in clinical medicine: neural network in lower gastrointestinal haemorrhage. Lancet 2003; 362: 1250-1251
43. Lisboa PJ. A review of evidence of health benefit from artificial neural networks in medical intervention. Neural Network 2002; 15: 11-39